Drug Profile
Research programme: DNA vaccines - Superview Biotechnology
Latest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Superview Biotechnology
- Class DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rabies
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for research development in Rabies in China (Parenteral)
- 12 Mar 2014 Early research in Rabies in China (Parenteral)